Skip to main content
Fig. 2 | BMC Medical Genetics

Fig. 2

From: A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)

Fig. 2

DNA integrity assessed by PCR amplification of GLOBIN gene. DNA concentrations were determined by fluorometry. The GLOBIN gene was amplified with an amount of urine DNA comprised between 10 and 18 ng (4 μl of DNA sample) from each Filter (F). Amplification curves are shown from Pool 1 to Pool 4, respectively

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us